SIMULTANEOUS DETERMINATION OF VALSARTAN AND HYDROCHLOROTHIAZIDE BY FIRST-ORDER DERIVATIVE- ZERO CROSSING UV-VISIBLE SPECTROPHOTOMETRIC METHOD

A. Hakan AKTAS*, Ahmed MuhiAllawAhbabi

Department of Chemistry, Faculty of Arts and Sciences, Süleyman Demirel University, 62300 Isparta, Turkey.

 

ABSTRACT 

Background: Antihypertensive drugs are widely used to treat high blood pressure in patients. The aim of this study is to prepare various mixtures of valsartan and hydrochlorothiazide, to create a matrix effect in the drug, and to determine the determination of these active substances in drug samples after optimum conditions by first-order derivative spectroscopy method.

Method: In the first-degree derivative spectrophotometry method applied, valsartan and hydrochlorothiazide were dissolved in methanol and 100 mgL-1 solutions were prepared, and then the mixtures of these solutions were determined in spectrophotometry. After mixing, tablet (drug) sample was prepared and absorbance values were recorded and the first derivative spectrophotometric method was applied to the values obtained.

Results: As a result of the spectrophotometric determination of various mixtures of valsartan and hydrochlorothiazide used in the study, it was determined that the first-order derivative spectrophotometric method applied gave very consistent results.

Conclusion: The first-order derivative spectrophotometry method used in the study can be easily applied in routine analyzes in drug research laboratories.

Keywords: First Order Derivative Spectrophotometric Method, Hydrochlorothiazide, Valsartan.

 

INTRODUCTION

 

Today, a wide variety of drugs are used for various purposes and new ones are added to them every day. The active parts of the drugs are the active ingredients of the drugs. Accurate determination of the amounts of active pharmaceutical ingredients during both manu-facturing and market controls is very important in terms of use. Medicines with missing active ingredients do not show the required benefit and when the side effects of the drugs are taken into account, those with too much active ingredient cause many harmful side effects. Since drug active ingredients are found in different matrices in different drugs, it is also important scientifically to determine them correctly1.It is observed from the studies that classical analytical methods and chemometric calibrations are used with increasing intensity in the analysis of pharmaceutical preparations, since they give successful results in the analysis of mixtures. Pharmaceutical preparations consist of a fixed matrix of excipients and one, two or more active samples containing the compound. Simultaneous quantitative analysis of combined pharmaceutical preparations without any separation or using a pre-separation process is extremely important in analytical chemistry. It is possible to carry out simultaneous quantitative determination of drug preparations in combination with Derivative spectro-photometer without any separation process. In addition, since graphical detail will also increase with increasing selectivity with the method of taking derivatives, analyzes performed on preparations containing a single active ingredient of the drug are performed more easily. With the use of diuretic mixtures, it is aimed to increase the effectiveness by obtaining synergistic effects. Combinations of thiazides and diuretics are often used in complex mixtures. The advantages of complex drugs include low dosages and increase the activity of hypertension.Valsartan (VAL) is a new antihypertensive drug belonging to the family of angiotensin II receptor antagonists. It is used in the treatment of hypertension and heart failure to reduce cardiovascular mortality in patients with left ventricular dysfunction following myocardial infarction. Hydrochlorothiazide (HCT)[6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfo-namide -1, 1-dioxide] is a diuretic effective on the distal convoluted tubule. Its molecular weight is 297.7 g/mol and its closed molecular formula is C7H8ClN3O4S2. Due to their synergistic antihyper-tensive effects, valsartan and hydrochlorothiazide are commercially available as a combined dosage form.

Various methods for the determination of the amount of VAL2-5 or HCT6-11 individually or in combination with other antihypertensive drugs in various matrices have been found in the literature search. Although the individual appointments of both drugs are not preferred due to the high cost and low efficiency of the studies to be conducted, they have been encountered at least a little in the literature research conducted again. Methods such as HPLC methods12-15, HPLC and first derivative of the ratio spectrophotometry16, spectro-fluorimetric method17,18, capillary electro-phoresis19,20 and UPLC21,22,23 for HCT and VAL and others analysis have been found in the literature. In this study, it was tried to determine the active drug substances by derivative spectrophotometer in a drug formulation where VAL and HCT, which are very difficult to determine by classical UV methods, due to their absorbance in very close places.

 

MATERIALS AND METHODS

 

Apparatus 

Measurements were made with a computer-controlled UV 1700 PHARMASPEC SHIMADZU spectrophoto-meter equipped with a 1 cm long cell. The spectra were read in the computer environment with the help of the up-to-date software of the device, and the data were evaluated with Excel and turned into graphics. Two transparent quartz cuvettes were used for absorbance measurements in the device.

Chemical and reagents

VAL and HCT and dosage forms (Diostar-Plus®) were supplied by Pharma International (Jordan). Methanol (Merck) was chromatographic grade. All other chemicals were used in analytical purity. All solutions were analyzed on the same day as they were prepared.

Solutions used

In the experimental phase of the study, stock solutions of drug active ingredients valsartan and hydrochloro-thiazide were prepared as 100 ppm for UV-Vis spectrophotometric measurements and dilution was carried out to the range to be studied. Five different solutions were prepared with concentration ranges of 5.2-26 ppm for valsartan and 0.8-4.0 ppm for hydrochlorothiazide in 25 mL flasks, and the spectra of these solutions were recorded between 200-350 nm in a UV-Vis spectrophotometer. For increasing concentra-tions, the highest absorption was observed at 255 nm for valsartan and 271 nm for hydrochlorothiazide, and a line showing the highest R2 value was obtained by graphing the absorbance values of these points against the wavelength values. As described in the tablet analysis section, the spectra of the tablet solutions prepared at certain concentrations were taken, the wavelength corresponding to the maximum absorbance values was used, and these values were evaluated on the calibration chart and the amounts of valsartan and hydrochlorothiazide in the tablets were calculated. These procedures were repeated at least four times and evaluated statistically.

Analysis of tablet

Ten tablets containing VAL and HCT as active ingredients were weighed into powder and weighed. Then, dilution was performed by transferring it to the measured balloon. It was sonicated with methanol for at least 30 minutes and then made up to volume with the same solvent. Subsequently, it was centrifuged and further dilution was made using methanol for the derivatization procedure.

 

RESULTS AND DISCUSSION

 

In the determination studies carried out by creating a calibration graph, the calibration graphs drawn for both active components were used. Figure 1 and Figure 2 show the normal UV spectra of valsartan and hydrochlorothiazide and their first derivative spectra plotted in excel. The point to be considered in the determination of the active substances in the mixture by derivative spectrophotometric method is the points where the absorbance of hydrochlorothiazide is zero in the derivative spectrum while determining the valsartan, and the points where the derivative absorbance of valsartan is zero should be selected when determining the hydrochlorothiazide. Thus, when two active substances are together, their determination can be made with accuracy.

As can be seen from the derivative spectra in Figure 2, these values are 271 nm for valsartan and 243 nm for hydrochlorothiazide. Working graphs drawn using these derivative absorbance values are given in Figure 3 and Figure 4. The results obtained when the method was applied to the commercial tablet sample containing both substances together are shown in Table 1.

 

CONCLUSION

 

In this study, first-order derivative spectrophotometry method is proposed for simultaneous determination of VAL and HCT in binary mixtures. This method has been successfully applied to pharmaceutical products. It was observed that the determination of overlapping drug mixtures gave accurate results with the proposed method. The proposed first-order derivative spectrophotometry method has been found to be applicable for routine analysis of drug mixtures without any pre-chemical separation and without the need for time of pharmaceutical formulation.

 

CONFLICT OF INTEREST

 

There is no conflict of interest regarding the work done.

 

AUTHOR’S CONTRIBUTION

 

One of the authors, A. Hakan Aktas, planned the experiments and carried out the writing process. The other author, Ahmed Muhi, contributed to the study by conducting experiments in laboratory conditions.

 

ACKNOWLEDGEMENTS 

 

The authors thank the Chemistry Department Chair for allowing the laboratories where the experiments were carried out.

 

REFERENCES 

 

  1. Parlak, H, Çakal Arslan, Ö, Boyacioglu, M, Karaaslan, MA. Ecotoxicology. Ege University Faculty of Fisheries Publications 2009; 328s: Izmir
  2. Elshanawane AA, Abdelaziz LM, Kamal MM, Hafez HM. Quantitative determination of fourangiotensin-II- receptor antagonists in presence of hydrochlorothiazide by agradient technique HPLC in their pharmaceutical preparations. J Liquid Chroma Related Tech 2014; 37(2): 171-186.https://doi.org/10.1080/10826076.2012.738620
  1. Sechaud R, Graf P, Bigler H, Gruendl E, Letzkus M, Merz MF. Pharmacokinetic and safety profiles of a fixed dose combination of Amlodipine, Valsartan, and Atorvastatin: A 3-period replicate crossover study. Int J Clin Pharmacol Ther 2002; 40(1):35-40. https://doi.org/1002/cpdd.727
  2. Daneshtalab N, Lewanczuk RZ, Jamali F.High-performance liquid chromatographic analysis of angiotensin II receptor antagonist valsartan using a liquid extraction method.J Chromatogr B Analyt Technol Biomed Life Sci 2002; 766(2):345-349.https://doi.org/10.1016/S0378-4347(01)00507-2
  1. Macek J, Klima J, Ptacek P. Rapid determination of valsartan in human plasma by protein precipitation and high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2006; 832(1):169–172.https://doi.org/10.1016/j.jchromb.2005.12.035
  1. Bianchini RM.Castellano PM. Kaufman TS. Stress testing of Valsartan. Development and validation of a high-performance liquid chromatography stability-indicating assay. J Liquid Chrom Related Tech 2012; 35 (8): 1053-1069. https://doi.org/10.1080/10826076.2011.615094
  2. Vetuschi C, Giannandrea A, Carlucci G, Mazzeom P. Determination of hydrochlorothiazide and irbesartan in pharmaceuticals by fourth-order UV derivative spectrophotometry. Farmaco 2005; 60(8):665–670.https://doi.org/10.1016/j.farmac.2005.04.013
  1. Zendelovska D, Stafilov T, Milosevski P. Development of solid-phase extraction method and its application for determination of hydrochlorothiazide in human plasma using HPLC. Biomed Chromatogr 2004; 18(2):71–76.https://doi.org/10.1002/bmc.293
  1. Ramakrishna NV, Vishwottam KN, Manoj S, Koteshwara M, Wishu S, Varma DP. Sensitive liquid chromatography–tandem mass spectrometry method for quantification of hydrochlorothiazide in human plasma. Biomed Chromatogr 2005; 19(10):751–760. https://doi.org/10.1002/bmc.510
  2. Takubo T, Okada H, Ishii M, Hara K, Ishii Y. Sensitive and selective liquid chromatography-electrospray ionization tandem mass spectrometry analysis of hydrochlorothiazide in rat plasma. J Chromatogr B Analyt Tech Biomed Life Sci.2004; 806(2):199–203.https://doi.org/10.1016/j.jchromb.2004.03.060
  1. Liu F, Xu Y, Gao S, Zhang J, Guo Q. Determination of hydrochlorothiazide in human plasma by liquid chromatography/tandem mass spectrometry. J Pharm Biomed Anal 2007; 44(5):1187–1191.https://doi.org/10.1016/j.jpba.2007.04.020
  1. Vignaduzzo SE, Castellano PM, Kaufman TS. Development and validation of an HPLC method for the simultaneous determination of amlodipine, hydrochlorothiazide, and valsartan in tablets of their novel triple combination and binary pharmaceutical associations. J Liquid Chrom Related Tech  2011; 34 (19): 2383-2395.https://doi.org/10.1080/10826076.2011.591020
  1. Iriate G, Ferreiros N, Ibarrondo I, Alonso RM, Maguregui MI, Jimenez RM. Biovalidation of an SPE-HPLC fluorescence method for the determination of valsartan and its metabolite valery-4-hydroxyl valsartan in human plasma. J Sep Sci 2007; 30(14):2231–40.https://doi.org/10.1002/jssc.200700033
  1. Shaikh JSA, Raut S, Abdul A, Pathan MAAK. High performance liquid chromatographic assay of amlodipine, valsartan and hydrochlorothiazide simultaneously and its application to pharmaceuticals, urine and plasma analysis. J Chroma B-Analytical Tech Biomed Life Sci 2020; 1155. https://doi.org/10.1016/j.jchromb.2020.122295
  2. Tekkeli SEK. Development of an HPLC-UV method for the analysis of drugs used for combined hypertension therapy in pharmaceutical preparations and human plasma.  J Anal Methods Chem 2013. https://doi.org/10.1155/2013/179627
  3. Kul D, Dogan-Topal B, Kutucu T, Uslu B, Ozkan SA. High-Performance Liquid Chromatographic and first derivative of the ratio spectrophotometric determination of amlodipine and valsartan in their binary mixtures. J AOAC Int 2010; 93 (3): 882-890.
  4. Ragab MAA, Galal SM.Korany MA, Ahmed AR. First derivative emission spectrofluorimetric method for the determination of LCZ696, a newly approved FDA supramolecular complex of valsartan and sacubitril in tablets. Luminescence 2017; 32 (8): 1417-1425.https://doi.org/10.1002/bio.3339 
  1. Cagigal E, Gonzalez L, Alonso RM, Jimenez RM. pKa determination of angiotensin II receptor antagonists (ARA II) by spectrofluorimetry. J Pharm Biomed Anal 2001; 26(3):477–86.https://doi.org/ 10.1016/s0731-7085(01)00413-7
  1. Zeng L, Wu X, Li YX, Lu D, Sun CJ. Multiwalled carbon nanotube-dispersive solid-phase extraction followed by high performance capillary electrophoresis for simultaneous determination of six adulterants in antihypertensive functional foods. Anal Meth 2015; 7 (2): 543-550.https://doi.org/10.1039/c4ay02416h
  1. Hillaert S, Van den Bossche W. Optimization and validation of capillaryzone electrophoretic method for the analysis of several angiotensin II receptorantagonists. J Chromatogr A 2002; 979(1–2):323–33.https://doi.org/10.1016/s0021-9673(02)01247-5
  1. Vojta J, Jedlicka A, Coufal P, Janeckova L. A new, rapid, stability-indicating UPLC method for separation and determination of impurities in amlodipine besylate, valsartan and hydrochlorothiazide in their combined tablet dosage form. J Pharma Biomed Anal 2015; 109: 36-44.https://doi.org/10.1016/j.jpba.2015.01.059
  1. Lahsini R, Monser L. Development of a new UPLC method for simultaneous determination of valsartan, amlodipine besylate, and hydrochlorothiazide pharmaceutical products. Acta Chroma 2015; 27 (3): 449-460.https://doi.org/10.1556/AChrom.27.2015.3.4  
  1. AKTAS AH. UV spectroscopy determination of cilazapril and hydrochlorothiazide active agents used in the treatment of hypertension. Universal J Pharm Res 2020; 5(6):49-51.https://doi.org/10.22270/ujpr.v5i6.512